Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide - Market Summary, Competitive Analysis and Forecast to 2025


The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the pharmaceuticals industry and had a total market value of $242.7 billion in 2020. China was the fastest growing country with a CAGR of 11.9% over the 2016-20 period.
  • Within the pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $169.4 billion in 2020. This was followed by Russia, Brazil and India with a value of $28.4, $23.6, and $21.4 billion, respectively.
  • China is expected to lead the pharmaceuticals industry in the BRIC nations with a value of $300.9 billion in 2025, followed by Russia, India, Brazil with expected values of $38.5, $29.3 and $28.3 billion, respectively.


  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ BRIC operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the BRIC pharmaceuticals market with five year forecasts
  • Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country

Reasons To Buy

  • What was the size of the BRIC pharmaceuticals market by value in 2020?
  • What will be the size of the BRIC pharmaceuticals market in 2025?
  • What factors are affecting the strength of competition in the BRIC pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the BRIC pharmaceuticals market?